Emergent Biosolutions INC S-1 registration statements
Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.
NYSE
Emergent BioSolutions Inc. has filed a registration statement to allow the sale of over 3.6 million shares and 2.5 million warrants by lenders who recently provided a $250 million term loan to the company.
NYSE
Emergent BioSolutions has filed a registration statement for the resale of up to 3,613,338 shares of common stock and warrants to purchase up to 2,500,000 shares of common stock by selling securityholders.